INTRODUCTION
============

Vesicular traffic begins when GTPases of the Sar/Arf family recruit protein coat complexes from the cytosol onto membranes. There are three major coat complexes in the cell: COPII, COPI, and clathrin. At the endoplasmic reticulum (ER), the COPII coat complex initiates the formation of ER-derived vesicles ([@B4]). This coat consists of an inner shell (Sec23/Sec24) that sorts cargo and an outer shell (Sec13/Sec31) or cage ([@B16]). The inner shell, or coat adaptor (Sec23/Sec24), is recruited to the ER by the activated form of Sar1 (Sar1-GTP) via an interaction with the Sec23 subunit, while the Sec24 subunit directly binds to and captures cargo into the nascent vesicle. Recruitment of the outer shell of the coat, Sec13/Sec31, leads to coat polymerization and vesicle budding ([@B4]).

It was initially thought that the vesicle-tethering machinery, which links the vesicle to its target membrane, recognizes and binds to an uncoated vesicle. However, in 2007, we reported the unexpected finding that an ER--Golgi tethering factor, TRAPPI, recognizes a COPII vesicle by binding the coat adaptor that sorts cargo into the vesicle ([@B8]). This result was surprising, because it was thought at the time that all vesicles uncoat soon after they bud. The COPII coat, in particular, was considered to be unstable and to be released from the vesicle without the aid of uncoating factors ([@B2]). Our observation not only implied that the COPII coat adaptor plays a role in targeting a vesicle to its correct intracellular destination, it also suggested there was an active mechanism for uncoating these vesicles. Since we reported these findings, other coat complexes (AP-3 adaptor complex, retromer, and COPI) have also been shown to play a role in vesicle targeting ([@B1]; [@B43]; [@B48]).

In this paper, we describe a proteomic screen and genetic studies that connect the J-domain chaperone auxilin, which is required to uncoat clathrin-coated vesicles ([@B22]; [@B12]), to the COPII and COPI coat complexes. In support of the proposal that auxilin may facilitate the uncoating of COPII and COPI vesicles, a proteomic approach has revealed a change in the assembly state of these coats in auxilin-depleted yeast cells. Genetic and biochemical studies confirm that auxilin interacts with subunits of both complexes. Additionally, the analysis of a *swa2*∆ mutant, which lacks auxilin, leads to a delay in ER--Golgi and intra-Golgi traffic at 15°C. In vitro transport studies link this delay to a defect in COPII vesicle fusion. Together these findings reveal an unexpected role for auxilin in the early secretory pathway.

RESULTS
=======

Proteomic analysis of clathrin-coated vesicle fractions from auxilin-depleted cells links auxilin to COPII and COPI coat structures
-----------------------------------------------------------------------------------------------------------------------------------

To identify additional components in clathrin-coated vesicles (CCVs), including potential cargo and novel adaptor proteins, we fractionated CCVs from yeast ([@B21]) and subjected the peak clathrin column fractions from a Sephacryl S-1000 column to mass spectrometry proteomic analysis (see *Materials and Methods* for details). As the depletion of auxilin might stabilize CCVs, this analysis was performed with both a wild-type strain (SL1463) and a *GAL1p:SWA2* strain (SL4827) ([@B31]) that was depleted for auxilin by shifting cells from galactose to glucose medium (Supplemental Tables S3 and S4). As expected, major peptide hits from both the Swa2-depleted and wild-type strains included clathrin heavy and light chains, the subunits of the *trans*-Golgi network (TGN)/endosomal AP-1 adaptor complex, and several membrane proteins known, or likely, to be sorted into TGN/endosomal-associated CCVs (see Supplemental Tables S5 and S6 and [Figure 1](#F1){ref-type="fig"}). Neither endocytic coat proteins or actin-associated endocytic factors were isolated in the wild-type or the auxilin-depleted strain, supporting prior studies indicating that clathrin-mediated endocytic vesicle uncoating is rapid and mediated by other factors, such as synaptojanin Sjl2, Ark1/Prk1 kinases, Arf3/Gts1/Lsb5, and cofilin ([@B38]; [@B41]; [@B6]).

![Major coated vesicle components identified in the proteomic analysis of Sephacryl S-1000 fractions from wild-type and auxilin-depletion strains. Shown are clathrin coats and the TGN/endosome adaptor AP-1, ER/Golgi coats COPI and COPII, and several COP-vesicle membrane proteins. Red, hits identified only in the auxilin-depletion strain; yellow, hits found in both wild type and *swa2∆*; green, found only in wild type; and white, not detected.](127fig1){#F1}

Subtraction of the proteins identified in the wild-type CCV fractions from those found in the auxilin-depleted fractions allowed us to eliminate many proteins specific to clathrin-mediated transport, as well as nonspecific hits, such as metabolic enzymes, viral particles, ribosomal subunits, and proteins involved in translation (Supplemental Tables S5--S7). A number of late Golgi/endosomal/vacuolar membrane cargoes were found in the auxilin-only data set (Supplemental Table S7), but several known to be sorted by clathrin may merely be less abundant or less stable CCV components. Although a retromer subunit (Vps17) and eisosome components (Lsp1 and Pil1) were found in the column fractions from the auxilin-depleted lysate, other subunits from these complexes (Pep8/Vps26 and Sur7, respectively) were also found in the wild-type CCV fractions, suggesting these constituents are not auxilin specific.

To our surprise, instead of identifying novel CCV adaptor proteins and cargo, we found proteins associated with COPII- and COPI-coated vesicles in the auxilin-depleted fractions (see Supplemental Tables S5--S7; [Figure 1](#F1){ref-type="fig"}). These included the subunits of the inner shell of the COPII coat complex, Sec23 and Sec24, and the COPI coat subunits Sec26, Ret2, and Sec27 ([@B7]; [@B13]). Additionally, several membrane proteins present in COPII vesicles, such as p24 family members ([Figure 1](#F1){ref-type="fig"} and Supplemental Table S7; [@B35]; [@B18]) and the Erv14 and Emp47 ER cargo receptors ([@B34]; [@B17]), were only found in the auxilin-depleted fractions. Together these data suggest that COPII- and COPI-coated vesicles copurify with CCVs in *swa2Δ* mutant fractions.

The CCV purification protocol and proteomics were also applied to a *chc1∆* strain expressing auxilin (*SWA2*). As expected, clathrin and its adaptors were absent in *chc1∆ SWA2* Sephacryl S-1000 fractions. Importantly, no significant hits for COPII vesicle ER vesicle membrane proteins or COP coat subunits were obtained. Many of the common/nonspecific hits from the *CHC1 SWA2* and the auxilin-depletion strains, however, were also found in the same fractions from the *chc1∆* strain (V.A.S. and S.K.L., unpublished observations). These data indicate that the early-stage vesicle transport proteins only significantly accumulate in the absence of auxilin. Thus, in addition to auxilin's known function for uncoating clathrin-coated vesicles, its modulation of the assembly state of the COPII and COPI coat complexes is also implicated by this analysis.

The loss of *SWA2Δ* leads to synthetic growth defects when combined with mutations in subunits of the COPII and COPI coat complexes
-----------------------------------------------------------------------------------------------------------------------------------

Concurrent with the proteomic study described above, we used a genetic approach to identify factors that could interact with COPII-coated vesicles. To our surprise, when we crossed the *swa2Δ* mutant to three different temperature-sensitive (ts) mutants (*sec23-1*, *sec24-1*, and *sec31-1*) that harbor mutations in subunits of the COPII coat complex ([@B3]), the haploid double mutants we obtained (*swa2Δ sec23-1*, *swa2Δ sec24-1*, and *swa2Δ sec31-1*) displayed growth defects that were more pronounced than either of the single mutants alone ([Figure 2A](#F2){ref-type="fig"}). For the *swa2Δ sec23-1* mutant, the exaggerated growth defect was most pronounced at 25°C, while the *swa2Δ sec24-1* and *swa2Δ sec31-1* double mutants were more impaired for growth at 30 and 34°C, respectively. Similar results were obtained when we crossed the *swa2Δ* mutant to a ts mutant that harbored a mutation in the Sec21 COPI coat subunit (*sec21-1*), while a double mutant with a mutation in another COPI subunit, Sec27, was only slightly impaired ([Figure 2B](#F2){ref-type="fig"}). Together these findings indicate that *SWA2* genetically interacts with genes encoding subunits of the COPII and COPI coat complexes.

![Deletion of *SWA2Δ* exacerbates the ts growth defects of *sec* mutants that harbor mutations in COPII (A) and COPI (B) coat subunits. Yeast cells were cultured at 25°C in YPD medium to early stationary phase before the cells (∼1 × 10^8^ cells/ml) were serially diluted (10-fold) and spotted onto YPD plates. The plates were incubated at the indicated temperatures for 4--7 d.](127fig2){#F2}

The tetratricopeptide repeat domain in auxilin binds directly to the N-terminus of the COPII coat subunit Sec31
---------------------------------------------------------------------------------------------------------------

The experiments described above prompted us to determine whether auxilin physically interacts with subunits of the COPII and COPI coat complexes. Initial binding studies were performed with the COPII coat, as we can purify sufficient amounts of each subunit of this coat complex from bacteria for direct binding experiments. Genetics linked auxilin to the Sec23, Sec24, and Sec31 subunits ([Figure 2](#F2){ref-type="fig"}), while proteomics linked auxilin to Sec23 and Sec24 ([Figure 1](#F1){ref-type="fig"}). Given that auxilin is known to interact with clathrin, which forms the cage of clathrin-coated vesicles ([@B42]), we initiated binding studies with the COPII cage subunits Sec31 and Sec13 ([@B47]; [@B26]). Because full-length Sec31 is a very large protein and not expressed well in bacteria, binding studies were performed with fragments of Sec31 (aa 1--500, aa 501--878, aa 879--1114, and aa 1115--1274) fused to glutathione *S*-transferase (GST). His~6~-auxilin bound directly to GST-Sec31 (aa 1--500), and not the other fragments of Sec31 ([Figure 3A](#F3){ref-type="fig"}). Additionally, the binding of His~6~-Auxilin to GST-Sec31 (aa 1--500) was concentration dependent ([Figure 3B](#F3){ref-type="fig"}). Consistent with our proteomic data, we also observed an interaction with auxilin and GST-Sec23 and GST-Sec24, but not GST or GST-Sec13 ([Figure 3A](#F3){ref-type="fig"} and Supplemental Figure S1, A and B). Thus in vitro binding studies demonstrate that auxilin directly interacts with multiple COPII coat subunits.

![The N-terminus of Sec31 directly binds to the TPR domain of auxilin. (A) Purified recombinant GST, GST-Sec13, and fragments of Sec31 (aa 1--500, 501--878, 879--1114, 1115--1274) fused to GST were prebound to glutathione beads and incubated with His~6~-auxilin, washed, and analyzed by Western blot analysis using anti-His~6~ antibody. (B) Top, GST and GST-Sec31 (aa 1--500) were incubated with His~6~-auxilin at different concentrations and processed for Western blot analysis. Bottom, Ponceau S stain of the binding reactions shows equal loading of GST and GST-Sec31 (aa 1--500). (C) Purified GST and GST fusion proteins were incubated with His~6~-Sec31 (aa 1--500) and pull-downs with glutathione beads were processed as described in *Materials and Methods*. The GST fusion proteins include GST-auxilin-CB (clathrin-binding region, aa 1--362), GST-auxilin-TPR domain (aa 363--561), and GST-auxilin-J domain (aa 562--668).](127fig3){#F3}

Yeast auxilin has a N-terminal clathrin-binding domain followed by a tetratricopeptide repeat (TPR) domain and a C-terminal J domain that stimulates the ATPase activity of Ssa1 ([@B31]; [@B45]). To determine which domain of auxilin binds to the COPII coat complex, we incubated His~6~-Sec31 (aa1--500) with GST fusions of each of these regions. His~6~-Sec31 (aa 1--500) bound to the TPR domain, but not to the other two domains of auxilin ([Figure 3C](#F3){ref-type="fig"}). TPR domains can serve as platforms for protein--protein interactions ([@B10]). Interestingly, deletion of the TPR domain of auxilin but not the N-terminal clathrin-binding region has been reported to result in a growth defect ([@B45]). Because disrupting the early secretory pathway impairs growth, the observation that Sec31 binds to a domain in auxilin that is important for growth is consistent with the possibility that auxilin acts on the early secretory pathway.

Auxilin coprecipitates with the COPI coat subunit called COP1
-------------------------------------------------------------

Our proteomics and genetic experiments have also linked auxilin to the COPI coat complex. However, because we were unable to express several of the COPI coat cage subunits in bacteria, we asked whether this coat complex coprecipitates with auxilin. To do this, we precipitated the COPI complex with immunoglobulin G (IgG)--Sepharose beads from a lysate containing tandem affinity purification (TAP)-tagged COP1. Bound protein was eluted, and then Western blot analysis was performed ([Figure 4A](#F4){ref-type="fig"}). Auxilin only coprecipitated with TAP-COP1 from tagged ([Figure 4A](#F4){ref-type="fig"}, top left, lanes 4, 6, and 8) but not untagged lysate (lanes 3, 5, and 7). Furthermore, the COPII coat subunit Sec24, which was used as a specificity control, was not detected in the precipitate ([Figure 4A](#F4){ref-type="fig"}, left bottom panel). As an additional specificity control, we examined another auxilin binding partner, clathrin. When clathrin was precipitated from a lysate containing TAP-tagged clathrin heavy chain (Chc1; [Figure 4B](#F4){ref-type="fig"}), auxilin ([Figure 4B](#F4){ref-type="fig"}, top left) but not the COPI coat subunit Sec28 ([Figure 4B](#F4){ref-type="fig"}, bottom left) was precipitated. Together these findings indicate that the coprecipitation of COP1 with auxilin is specific.

![Auxilin coprecipitates with the COPI coat complex. (A) Left, increasing amounts of lysate, prepared from a COP1-TAP--tagged (SFNY1415) or untagged (SFNY 998) strain, were incubated with 30 μl of IgG--Sepharose beads for 2 h at 4°C. The beads were washed, eluted, and then processed for Western blot analysis using anti-auxilin and anti-Sec24 antibodies (1:1000 dilution). Right, anti-coatomer antibody was used to monitor the presence of COP1-TAP in the IgG pull-down. (B) The same as A, but the lysate was prepared from a Chc1-TAP--tagged strain (SFNY1741) and processed for Western blot analysis using anti-auxilin and anti-Sec28 (left) antibodies, or anti-Chc1 antibody (right) at 1:1000 dilution.](127fig4){#F4}

The loss of auxilin disrupts secretion
--------------------------------------

If the interaction of auxilin with the COPII and COPI coat complexes is functionally important, the loss of *SWA2*Δ should lead to defects in general secretion. While previous studies showed a defect in TGN-mediated pro-α-factor processing in the *swa2Δ* mutant, no obvious effect on the kinetics of secretion was observed at 30°C ([@B14]). As trafficking defects in the early secretory pathway impair growth, we reasoned that defects in secretion may only be revealed in *swa2*Δ cells at a temperature at which growth is dramatically impacted. Consistent with earlier studies, we observed that the *swa2Δ* mutant grows slowly at several temperatures ([@B14]; [@B11]) but is most impaired at 15°C ([Figure 5A](#F5){ref-type="fig"}). Therefore we performed our experiments at this lower temperature.

![General secretion is delayed in *swa2Δ* cells at 15°C. (A) The growth of the *swa2Δ* mutant (SFNY2683) was compared with wild type (SFNY1842) on a YPD plate at 15°C. (B) Secretion analysis: Left, wild type (SFNY1842; lanes 1--3) and the *swa2Δ* mutant (SFNY2683; lanes 4--6) were incubated for 60 min at 15°C and then pulse labeled at the same temperature with \[^35^S\]ProMix for the indicated time points. Proteins secreted into the medium were analyzed as described in *Materials and Methods*. Secreted p150 is marked. Right, quantification of the percent secretion of p150 into the medium at 15 and 20 min from three independent experiments. Error bars represent SD. \*, *p* \< 0.05, Student's t test.](127fig5){#F5}

The *swa2Δ* mutant and its isogenic wild-type strain were shifted to 15°C for 60 min and then labeled with \[^35^S\]ProMix at the same temperature. Proteins secreted into the medium were collected at various times after labeling and analyzed on a 6% SDS polyacrylamide gel. By 15 min, several proteins, including p150, were secreted into the medium in wild-type but not *swa2Δ* cells ([Figure 5B](#F5){ref-type="fig"}, left, lanes 1 and 4). By 25 min, the observed delay in secretion in the mutant was still pronounced ([Figure 5B](#F5){ref-type="fig"}, compare lanes 3 and 6). Quantification of the p150 band ([Figure 5B](#F5){ref-type="fig"}, right) from three separate experiments revealed a dramatic delay in secretion in the mutant at the 15- and 20-min time points, confirming that the loss of auxilin leads to an obvious delay in general secretion.

The loss of auxilin delays both ER--Golgi and intra-Golgi traffic in vivo
-------------------------------------------------------------------------

If the delay in secretion in the *swa2Δ* mutant is a consequence of disrupting COPII and COPI function, ER--Golgi and intra-Golgi traffic should be impaired. To address this possibility, we monitored the trafficking of the vacuolar protease carboxypeptidase Y (CPY). CPY traffics from the ER (p1 form) to the early (p1′) and late Golgi (p2) before it is proteolytically cleaved to the mature form in the vacuole ([@B40]). For monitoring the trafficking of CPY in wild type and the *swa2Δ* mutant, cells were preincubated at 15°C for 1 h, pulse labeled for 10 min, and chased for various times at 15°C ([Figure 6A](#F6){ref-type="fig"}). A delay in the conversion of p1 to p2 CPY was observed in the *swa2Δ* mutant throughout the chase period ([Figure 6A](#F6){ref-type="fig"}, compare lanes 1--6 with lanes 7--12; see [Figure 6B](#F6){ref-type="fig"} for quantification). Additionally, we also observed that CPY migrated more heterogeneously in the mutant as it was processed from the p1 to the p2 form, suggesting that some CPY may be trapped as p1′ CPY, a form which is difficult to see in wild type ([Figure 6A](#F6){ref-type="fig"}, compare lanes 3--6 with 10--12). Together these findings imply that the loss of auxilin leads to a kinetic delay in the trafficking of CPY between the ER and Golgi and within the Golgi complex. As extensive studies with several different clathrin mutants have shown that traffic through the early secretory pathway occurs normally in the absence of clathrin function ([@B30]; [@B29]; [@B36], [@B37]; [@B23]), the most likely interpretation of our data is that the observed delay in secretion in the *swa2Δ* mutant is a consequence of disrupting COPII and COPI function.

![ER--Golgi and intra-Golgi traffic are delayed in the *swa2Δ* mutant. (A) CPY processing: wild type (SFNY1842; lanes 1--6) and the *swa2Δ* mutant (SFNY2683; lanes 7--12) were shifted to 15°C for 60 min, pulse labeled for 10 min, and chased for the indicated times. CPY was immunoprecipitated from lysates and processed as described in *Materials and Methods*. The p1 (67 kDa), p2 (69 kDa), and mature (m; 61 kDa) forms of CPY are indicated. (B) Quantification of the ratio of p2CPY/p1CPY from three independent experiments. Error bars represent SD. \*, *p* \< 0.05, Student's t test. (C) Invertase processing and transport: wild-type and *swa2∆* cells were shifted to 15°C for 1 h and then incubated at the same temperature for 30 min in low-glucose medium (to induce extracellular invertase expression) in the presence of \[^35^S\]ProMix. The cells were converted to spheroplasts and pelleted. Then invertase was immunoprecipitated from the cell pellet fraction (Internal; lanes 1--3) and spheroplast supernatant fractions (External; lanes 4 and 5). Cytoplasmic invertase, glycosylated ER, and Golgi forms of invertase are indicated. Lane 3, a darker exposure of sample shown in lane 2.](127fig6){#F6}

To confirm this observation with a second protein that trafficks through the early secretory pathway, we monitored the trafficking of the secreted protein invertase. There are two forms of invertase, a cytoplasmic and a secreted form. The cytoplasmic form is constitutively made, while the secreted form is derepressed in low-glucose-containing medium ([@B9]). Secreted invertase is translocated into the lumen of the ER, where it is N-glycosylated to yield an 80-kDa ER form. Before it is secreted into the periplasm, it is further glycosylated in the Golgi to a high-molecular-weight form that migrates heterogeneously on an SDS polyacrylamide gel ([@B27]). To determine whether the loss of auxilin disrupts invertase secretion, we shifted wild-type and *swa2Δ* cells to 15°C for 1 h before derepressing invertase for 30 min at 15°C in YP medium with 0.1% glucose in the presence of \[^35^S\]ProMix. At the end of the incubation, the cells were washed, converted to spheroplasts, and pelleted, and invertase was immunoprecipitated from the supernatant (external) and pelleted (internal) fractions. The *swa2Δ* mutant accumulated more of the ER form of invertase ([Figure 6C](#F6){ref-type="fig"}, compare lanes 1 and 2), indicating a delay in traffic from the ER to the Golgi complex. A higher-mole­cular-weight Golgi form of invertase ([Figure 6C](#F6){ref-type="fig"}, lanes 2 and 3) was also observed. Some of this form of invertase was secreted (lane 5). The Golgi form of invertase synthesized in the mutant migrated more slowly than the Golgi form in wild-type cells ([Figure 6C](#F6){ref-type="fig"}, compare lanes 3--5), suggesting a delay in Golgi traffic. Together these findings indicate that the loss of auxilin delays vesicle traffic between the ER and Golgi and within the Golgi complex, demonstrating a role for auxilin in the early part of the secretory pathway. We speculate that this function for auxilin was uncovered at 15°C, because cells grow more slowly at this temperature, which may delay the dissociation of the coat and unmask this early secretory defect.

Auxilin is required for COPII vesicle fusion in vitro
-----------------------------------------------------

Next we wanted to address the question of which step in COPII vesicle traffic requires auxilin. COPII vesicle budding, tethering, and fusion can be differentiated in an in vitro transport assay that reconstitutes vesicle traffic from the ER to the Golgi complex ([@B33]; [@B24]). For measuring ER--Golgi traffic in vitro, a radiolabeled cargo marker (\[^35^S\]prepro-α-factor) is first translocated into ER membranes that are retained within wild-type or *swa2∆* [p]{.ul}ermeabilized [y]{.ul}east [c]{.ul}ells (PYCs). Subsequent to translocation, the signal sequence of prepro-α-factor is cleaved in the ER, and the protein is N-glycosylated. Glycosylated pro-α-factor, retained within the PYCs, is then incubated with an S1 fraction (cytosol and Golgi membranes) that was obtained from either wild type or the *swa2Δ* mutant, respectively. Transport of pro-α-factor to the Golgi is monitored with the solid-phase lectin absorbant concanavalin A (ConA)--Sepharose, which binds only glycosylated pro-α-factor. Vesicle budding is measured as the ConA precipitable counts that are released from the PYCs, while membrane fusion is assessed with an anti outer-chain antibody that recognizes the Golgi form of carbohydrate on pro-α-factor. As shown in [Figure 7A](#F7){ref-type="fig"}, COPII vesicle fusion, but not vesicle budding, was decreased in the absence of auxilin.

![The *swa2Δ* mutant is defective in COPII vesicle fusion but not budding or tethering in vitro. (A) Vesicle budding (left) and fusion (right) were measured in fractions prepared from wild type and the *swa2Δ* mutant as described in *Materials and Methods*. Error bars represent SEM, *n* = 3. \*, *p* \< 0.05, Student's t test. (B) Top, fractionation of released transport vesicles: sucrose velocity gradient fractionation pattern of vesicles formed in vitro from wild-type permeabilized donor cells and cytosol. Bottom, vesicle tethering: the transport assay was performed with wild-type donor cells and a wild-type S1 fraction (black line) or *swa2Δ* mutant donor cells and a *swa2Δ* mutant S1 fraction (dotted line). At the end of the assay, the permeabilized donor cells were pelleted, and the supernatant was fractionated on a sucrose velocity gradient.](127fig7){#F7}

To address whether the observed defect in fusion in the *swa2Δ* mutant was direct, or an indirect consequence of the inability of the COPII vesicles to bind to the Golgi, we performed a vesicle-tethering assay ([@B5]). Transport reactions were performed as in [Figure 7A](#F7){ref-type="fig"}, except that free vesicles ([Figure 7B](#F7){ref-type="fig"}, top) were separated from vesicles that bound to the Golgi on a sucrose velocity gradient ([Figure 7B](#F7){ref-type="fig"}, bottom). COPII vesicles formed from the *swa2Δ* mutant or wild-type fractions bound to the Golgi with comparable efficiency ([Figure 7B](#F7){ref-type="fig"}, bottom). The bound vesicles in the *swa2Δ* mutant, however, were incompetent for fusion ([Figure 7A](#F7){ref-type="fig"}), indicating that the loss of auxilin leads to a specific defect in COPII vesicle fusion.

DISCUSSION
==========

The J-domain protein auxilin is primarily known for its role as a cofactor for Hsc70 in uncoating clathrin-coated vesicles ([@B22]; [@B12]; [@B19]). It binds to CCVs after scission and then recruits Hsc70 to the clathrin lattice via its J domain. Hsc70 interacts with the C-terminal region of the clathrin triskelion tripod for rapid ATP-dependent uncoating of clathrin-coated vesicles ([@B32]), a prerequisite for the fusion of the vesicle with its target membrane. Additional studies suggest that auxilin and Hsc70 have other roles during clathrin-mediated endocytosis ([@B12]). For example, at the cell surface, auxilin plays a role in the formation of CCVs by facilitating the exchange of clathrin during coated pit invagination and bud constriction ([@B44]; [@B28]; [@B46]; [@B39]). Auxilin and Hsc70 are also thought to have a chaperone role for the clathrin triskelion after it dissociates from CCVs, preventing it from aggregating in the cytosol and allowing it to rebind to uncoated membranes ([@B12]).

Auxilin and Hsc70 could have similar roles during COPII and COPI vesicle transport. These proteins may perform a chaperone role for individual subunits of the COPII coat or for the entire COPII complex. As vesicle budding was unaffected in vitro with fractions prepared from *swa2∆* cells, the data presented in our studies imply that auxilin is not required for COPII vesicle formation. The finding that auxilin facilitates membrane traffic in the early secretory pathway is consistent with a published fractionation study from our lab showing that auxilin cofractionates with ER membranes on sucrose gradients ([@B11]).

Our previous studies demonstrated that the uncoating of COPII vesicles is highly regulated, occurring after vesicles tether to the Golgi ([@B8]; [@B25]). In this paper, we show that, in the absence of auxilin, COPII vesicle tethering to the Golgi is unaffected in vitro, but fusion is blocked. This finding is consistent with a role for auxilin in the uncoating of docked COPII vesicles before fusion. Purified recombinant His~6~-auxilin was unable to restore fusion activity to *swa2∆* mutant fractions (unpublished data), but this may be because recombinant auxilin is not phosphorylated in bacteria. It has been speculated that the activity of auxilin, a known phosphoprotein, is regulated by phosphorylation ([@B14]; [@B22]). Phosphorylation of specific sites on auxilin may control the timing or rate at which different classes of vesicles uncoat, providing an additional layer of regulation to membrane fusion. Although our findings are consistent with a role for auxilin in COPII vesicle uncoating, we were unable to directly demonstrate a role for auxilin in this process. COPII cages from yeast coat subunits are not readily formed in vitro, and initial attempts to examine auxilin function in cage assembly/disassembly has not been straightforward (R. Lakshminarayan and E. Miller, personal communication). Nevertheless, our proteomics analysis showing accumulation of both COPII and COPI coat proteins and ER vesicle membrane cargo in the CCV fractions from auxilin-depleted cells implies that auxilin regulates the assembly state of COPII- and COPI-coated structures.

In summary, we have used here a variety of approaches to show that auxilin plays a role in the early secretory pathway in yeast. Further studies are underway to determine whether auxilin plays a similar early secretory role in animal cells. This is of significant interest, because several mutations in DNAJC6, which encodes the nerve specific auxilin, were recently found to cause recessive juvenile parkinsonism. Mutations in DNAJ26, which encodes the ubiquitous auxilin GAK, are implicated in Parkinson's disease susceptibility ([@B20]). It is speculated that such auxilin defects affect clathrin-mediated endocytosis at the synapse and thus dopamine receptor recycling. However, based on our findings, it will be important to consider whether early secretory pathway defects may be associated with these clinical manifestations of auxilin deficiency.

MATERIALS AND METHODS
=====================

Strains, growth conditions, and antibodies
------------------------------------------

All yeast and bacterial strains used in this study are listed in Supplemental Tables S1 and S2. Yeast cells were grown in YP (1% yeast extract, 2% peptone) plus 2% dextrose (YPD) or other carbon sources. For in vivo labeling experiments, cells were grown in synthetic complete or minimal medium with the appropriate amino acids and 2% dextrose.

Anti--6x His is from ThermoFisher (Waltham, MA), and anti-coatomer and anti-Sec28 antibodies were a gift from Rainer Duden (University of Lubeck). Anti-rabbit antiserum to auxilin, Sec24, CPY, and invertase were prepared in the Ferro-Novick laboratory.

Anti-Chc1 mouse monoclonal antibodies were prepared in the Lemmon laboratory ([@B21]).

Purification of enriched coated vesicle fractions for proteomics
----------------------------------------------------------------

Wild-type cells (SL1463) were grown in YPD. For the depletion of auxilin, a *GAL1p:SWA2* strain (SL4827/GPY2598) was grown to log phase in YP + 2% galactose, and then cultures were shifted to YPD for 15 h. For each strain, clathrin-coated vesicles (CCVs) were purified from 3 l of cells (∼5 × 10^7^/ml) that were harvested and processed for cell fractionation and Sephacryl S-1000 size-exclusion chromatography (1.5 × 100 cm column), as described previously ([@B21]). Peak Chc1 fractions (28--36) were assessed by SDS--PAGE and Coomassie Blue R250 staining of gels, pooled (6--7 fractions of 3 ml each) and concentrated ∼40- to 100-fold in centricon 10 (Millipore, Billerica, MA) or vivaspin 2 (Vivaproducts, Littletown, MA) microconcentrators. Samples were separated on 4--20% polyacrylamide precast Bio-Rad minigels (Bio-Rad Laboratories, Hercules, CA) and stained with Coomassie Blue R250 in 30% methanol and 5% acetic acid. Gel lanes were cut into 10--11 slices, and each slice was trypsinized and analyzed by mass spectrometry by Midwest Bio Services (Overland Park, KS; [www.midwestbioservices.com](http://www.midwestbioservices.com)).

Analysis of proteomics
----------------------

Peptide hits in each gel slice (Supplemental Tables S3 and S4) were compared with the *Saccharomyces cerevisiae* protein database using the SEQUEST algorithm (performed by Midwest Bio Services) and curated with the Protein Information Resource Peptide Matching analysis tool (<http://research.bioinformatics.udel.edu/peptidematch/index.jsp>). The data from individual slices were then combined and sorted to generate a composite list of hits for wild-type or the auxilin-depletion vesicle preparation (Supplemental Tables S5 and S6). Finally, to generate a list of protein hits specific to the auxilin-depletion strain, all of the gene products identified in the wild-type strain were subtracted from the hits obtained from the auxilin-depletion strain (Supplemental Table S7). During the purification of coated vesicles, RNase was added to the cell extract to remove polysomes ([@B21]), but ribosomal subunits and translation factors were still a common contaminant in the Sephacryl S-1000 coated-vesicle column fractions. Therefore all proteins involved in translation, including translation factors and ribosomal subunits, were excluded from the auxilin-depletion strain list.

Immunoprecipitation of the COPI coat complex
--------------------------------------------

For the TAP-tag immunoprecipitation experiments described in [Figure 4](#F4){ref-type="fig"}, lysates were prepared from a total of 3000 OD~600~ units of cells, pelleted, resuspended in 100 ml of spheroplast buffer (1.4 M sorbitol, 100 mM sodium phosphate, pH 7.5, 0.35% β-mercaptoethanol, and 0.5 mg/ml Zymolyase), and incubated for 30 min at 37°C. The spheroplasts were pelleted and washed twice with 150 ml of 1.7 M sorbitol and 20 mM HEPES (pH 7.4), and the spheroplast pellet was resuspended in 8 ml of lysis buffer (20 mM HEPES, pH 7.4, 4 mM EDTA, 1 mM dithiothreitol \[DTT\]) and Dounce homogenized. The resulting lysate was brought to 0.1 M NaCl, 1% NP-40, and incubated on ice for 20 min and then centrifuged for 30 min at 60,000 × *g*. The supernatants (4--12 mg protein) were then incubated with 30 μl of IgG--Sepharose beads (GE Healthcare) for 2 h at 4°C. The beads were washed three times with wash buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM DTT, 2.5 mM MgCl~2~, 1% Triton X-100, and a protease inhibitor cocktail that included 1 μg/ml of aprotinin, chymostatin, antipain, pepstatin, and leupeptin) before they were eluted in 20 μl of 3X SDS--PAGE sample buffer and analyzed by Western blotting.

In vitro binding assays with recombinant proteins
-------------------------------------------------

The expression of His~6~-tagged and GST-tagged fusion proteins was induced with 0.5 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside. All fusion proteins were purified as described in the *Recombinant Protein Purification* handbook from GE Healthcare. Purified His~6~-tagged fusion proteins (0.2 μM) were incubated with equimolar amounts of GST-fusion proteins or GST (0.2 μM) immobilized on glutathione--Sepharose beads (GE Healthcare) in binding buffer (25 mM Tris, pH 7.5, 300 mM KCL, 2% Triton X-100, 1 mM DTT, 1 mM EDTA, and the protease inhibitor cocktail described above) for 2--4 h at 4°C. The beads were washed three times with binding buffer, eluted in 30 μl of SDS--PAGE sample buffer by heating to 100°C for 5 min, and analyzed by Western blot analysis.

General secretion assay
-----------------------

Cells were grown overnight at 25°C to log phase, and 7.5 OD~600~ units were resuspended in 2 ml of fresh methionine-free medium containing 0.06 mg/ml bovine serum albumin and then shifted to 15°C for 60 min. After the incubation, the cells were labeled with 500 μCi of \[^35^S\]ProMix at 15°C, and aliquots of cells (350 μl) were removed at the end of the indicated time points. Labeled cell suspensions were centrifuged for 1 min at 13,000 × *g*, and then 300 μl of the medium (extracellular fractions) was transferred to an ice-cold tube containing 30 μl of stop mix (500 mM NaN~3~, 500 mM NaF). The extracellular fractions were centrifuged again for 1 min at 13,000 × *g* to remove residual cells, and the supernatant was transferred to a fresh tube containing 20 μl of 100% trichloroacetic acid (TCA) and 1 mg/ml sodium deoxycholate. All samples were incubated on ice for 60 min before the TCA precipitates were pelleted at 13,000 × *g* for 5 min and washed twice with ice-cold acetone. The acetone-washed pellets were air-dried, resuspended in 40 μl of 1X SDS sample buffer, heated to 100°C for 5 min, and subjected to SDS--PAGE using a 6% gel, followed by autoradiography.

Analysis of the transport and processing of CPY and invertase
-------------------------------------------------------------

For analysis of CPY processing, all strains (20 OD~600~ units) grown overnight at 25°C were resuspended in 4.5 ml of fresh minimal medium (supplemented with amino acids) and then shifted to 15°C for 60 min before being labeled with 500 μCi of \[^35^S\]ProMix for 10 min at 15°C. Cells (700 μl) were removed (0 min time point), and a chase mix (625 μl of 250 mM cysteine and 250 mM methionine) was added to the remaining sample. Additional aliquots (700 μl) were then removed at the indicated time points. Cells were washed twice with cold 10 mM sodium azide and resuspended in 125 μl of spheroplast buffer (1.4 M sorbitol, 50 mM potassium phosphate, pH 7.5, 10 mM sodium azide, 50 mM β-mercaptoethanol, 10 μg Zymolyase-100T/1 OD unit of cells). After a 45-min incubation at 37°C, spheroplasts were pelleted at 450 × *g* for 3 min, resuspended in 125 μl of 1% SDS, and heated for 5 min at 100°C. The samples were diluted with 900 μl of phosphate-buffered saline (PBS) containing 1% Triton X-100 and centrifuged for 15 min at 13, 000 × *g*. The supernatant (920 μl) was removed and incubated overnight with 3 μl of anti-CPY antibody (rabbit antiserum; Ferro-Novick laboratory) at 4°C. A 50% slurry of protein A--Sepharose (50 μl) beads was added to each sample, and samples were incubated for 1 h. The beads were then washed twice with urea wash buffer (2 M urea, 200 mM NaCl, 100 mM Tris, pH 7.6, 1% Triton X-100) and twice with 1% β-mercaptoethanol. The contents of the beads were solubilized in 70 μl of Laemmli sample buffer before they were subjected to SDS--PAGE using an 8% gel, followed by autoradiography.

For analysis of invertase secretion, 6 OD~600~ units of cells grown overnight at 25°C were resuspended in 6 ml of fresh minimal medium with 2% glucose (supplemented with amino acids) and then shifted to 15°C for 60 min. The cells were then transferred into medium containing 0.1% glucose to derepress the synthesis of invertase and labeled with 250 μCi of \[^35^S\]ProMix for 30 min at 15°C. After the incubation, the cells were washed twice with cold 10 mM sodium azide and resuspended in 125 μl of spheroplasting buffer for 45 min at 37°C and then centrifuged at 450 × *g* for 3 min. SDS (5 μl of 20% SDS) was added to 100 μl of the spheroplast supernatant (external), and the spheroplast pellet (internal) was resuspended in 125 μl of 1% SDS. Both samples were then heated for 5 min at 100°C. Aliquots (100 μl) of each sample were diluted with 900 μl of PBS containing 1% Triton X-100 and centrifuged for 15 min at 13,000 × *g*. The supernatant (920 μl) was removed and incubated overnight with 3.5 μl of anti-invertase antibody (rabbit antiserum; Ferro-Novick laboratory) before a 90-min incubation with 50 μl of a 50% slurry of protein A--Sepharose beads. The beads were then washed and solubilized as described above. Immunoprecipitated invertase was analyzed on a 10% polyacrylamide gel, which was subjected to autoradiography.

In vitro transport assay
------------------------

The in vitro transport assay was performed as previously described ([@B15]; [@B24]), using wild-type donor cells and a wild-type S1 fraction (prepared as described in the following section) or *swa2∆* donor cells and an *swa2∆* S1 fraction. Briefly, permeabilized donor cells were incubated with in vitro translated radiolabeled prepro-α-factor for 50 min at 15°C. Donor cells harboring ER-translocated pro-α-factor were then pelleted, washed, and incubated with an S1 fraction for 90 min at 15°C. At the end of the reaction, the cells were centrifuged at 13,000 × *g* for 1 min, and the supernatant (containing Golgi and released vesicles) and a cell pellet from each sample were incubated with ConA--Sepharose beads at 4°C for 2 h. The beads were then washed, and samples were eluted in 70 μl of 1X SDS gel sample buffer. Equal amounts (20 μl) of each sample were counted, and the percent of budding was calculated as the counts in the supernatant/supernatant + pellet. For determination of the fusion efficiency, 20 μl of the ConA-treated supernatant fraction was immunoprecipitated with an antibody that recognizes Golgi-specific α1-6 mannose side chains on pro-α-factor. The percent fusion was calculated as the precipitable pro-α-factor counts in the supernatant/total ConA counts in the supernatant and pellet. The budding and fusion of wild type was considered to be maximal (100%).

Preparation of S1 fractions for the transport assay
---------------------------------------------------

Cells (1500 OD~600~ units) grown overnight at 30°C to log phase were resuspended in 1 l of YP medium with 0.01% glucose and incubated at 25°C for 30 min. The cells were pelleted, resuspended in 500 ml of spheroplast buffer (YP, 0.01% glucose, 1.4 M sorbitol, 50 mM potassium phosphate, pH 7.5, 50 mM β-mercaptoethanol, 10 μg Zymolyase-100T/l OD unit of cells), and incubated at 37°C for 30 min. The spheroplasts were then resuspended in recovery medium (YP, 0.01% glucose, 1 M sorbitol) and incubated at 37°C for 90 min. The regenerated spheroplasts were gently lysed in 3.36 ml of 20 mM HEPES (pH 7.2) before being centrifuged at 1000 × *g* for 10 min. The supernatant was collected, snap frozen, and stored at −80°C.

Vesicle-tethering assay
-----------------------

The supernatants from 10 transport reactions were pooled and loaded onto a sucrose gradient consisting of the following steps of sucrose prepared in TBPS (25 mM HEPES, pH 7.2, 115 mM KOAc, 25 mM Mg(OAc)~2~, 268 mM sorbitol): 0.5 ml of 50% sucrose (wt/wt), 0.5 ml of 46% sucrose (wt/wt), 1 ml of 42% sucrose (wt/wt), 1.5 ml of 38% sucrose (wt/wt), 1.5 ml of 34% sucrose (wt/wt), 1.5 ml of 30% sucrose (wt/wt), 1.5 ml of 26% sucrose (wt/wt), 1.5 ml of 22% sucrose (wt/wt), and 1.5 ml of 18% sucrose (wt/wt). The gradient was centrifuged for 2 h and 20 min at 173,000 × *g*. At the end of the centrifugation, twelve 1 ml samples were removed starting from the top of the gradient. Each sample (200 μl) was then treated with ConA--Sepharose beads to affinity purify glycosylated pro-α-factor and processed as described above. The counts from each fraction were graphed to determine the fractionation of pro-α-factor.

The same experiment, as described above, was done to mark where free vesicles migrate on the gradient, but the reactions were performed with cytosol instead of an S1 fraction.
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CCV

:   clathrin-coated vesicles

Chc1

:   clathrin heavy chain

ConA

:   concanavalin A

CPY

:   carboxypeptidase Y

DTT

:   dithiothreitol

ER

:   endoplasmic reticulum

GST

:   glutathione *S*-transferase

IgG

:   immunoglobulin G

PBS

:   phosphate-buffered saline

PYC

:   permeabilized yeast cell

TCA

:   trichloroacetic acid

TGN

:   *trans*-Golgi network

TPR

:   tetratricopeptide repeat

ts

:   temperature-sensitive

YP

:   yeast--peptone

YPD

:   yeast--peptone--dextrose.
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